| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |